STATE STREET CORP
- SEC CIK
- 0000093751
VRTX holding history
VERTEX PHARMACEUTICALS INC / MA
Every 13F filing in which STATE STREET CORP reported holding VRTX, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 11,871,459 | $5.9B | 0.17% | +141,320+1.2% | Added |
| Q1 2026 | 11,730,139 | $5.24B | 0.18% | +40,600+0.3% | Added |
| Q4 2025 | 11,689,539 | $5.3B | 0.18% | +83,539+0.7% | Added |
| Q3 2025 | 11,606,000 | $4.55B | 0.16% | −169,227−1.4% | Reduced |
| Q2 2025 | 11,775,227 | $5.24B | 0.20% | −13,430−0.1% | Reduced |
| Q1 2025 | 11,788,657 | $5.72B | 0.24% | −190,748−1.6% | Reduced |
| Q4 2024 | 11,979,405 | $4.82B | 0.19% | +163,156+1.4% | Added |
| Q3 2024 | 11,816,249 | $5.5B | 0.22% | +90,173+0.8% | Added |
| Q2 2024 | 11,726,076 | $5.5B | 0.24% | −280,407−2.3% | Reduced |
| Q1 2024 | 12,006,483 | $5.02B | 0.22% | −77,335−0.6% | Reduced |
| Q4 2023 | 12,083,818 | $4.92B | 0.24% | +44,272+0.4% | Added |
| Q3 2023 | 12,039,546 | $4.19B | 0.23% | −292,047−2.4% | Reduced |
| Q2 2023 | 12,331,593 | $4.34B | 0.23% | +124,141+1.0% | Added |
| Q1 2023 | 12,207,452 | $3.85B | 0.22% | −162,978−1.3% | Reduced |
| Q4 2022 | 12,370,430 | $3.57B | 0.21% | +75,639+0.6% | Added |
| Q3 2022 | 12,294,791 | $3.56B | 0.23% | +30,742+0.3% | Added |
| Q2 2022 | 12,264,049 | $3.46B | 0.21% | +211,286+1.8% | Added |
| Q1 2022 | 12,052,763 | $3.15B | 0.16% | −304,152−2.5% | Reduced |
| Q4 2021 | 12,356,915 | $2.71B | 0.13% | +33,499+0.3% | Added |
| Q3 2021 | 12,323,416 | $2.24B | 0.12% | +617,593+5.3% | Added |
| Q2 2021 | 11,705,823 | $2.36B | 0.12% | +530,785+4.7% | Added |
| Q1 2021 | 11,175,038 | $2.4B | 0.14% | +11,175,038 | New |